Movement Alert|Thermo Fisher Scientific Falls 3.02% in Regular Trading, Piper Sandler Issues Neutral Rating as Life Sciences Sector Weakens

Market Focus06-12

On June 11, Thermo Fisher Scientific fell 3.02% in regular trading, trading at $467.23/share, with turnover of $290 million.

On the news front, Piper Sandler initiated coverage on Thermo Fisher Scientific with a Neutral rating and a $510 price target. This adds to the cautious tone set by HSBC, which previously downgraded the stock from Buy to Hold and slashed its price target from $670 to $540. Multiple institutions now hold a reserved outlook on the stock, creating sustained pressure. The current share price remains well below the analyst consensus target of $602.50.

The broader Life Sciences Tools & Services sector experienced notable weakness, amplifying the downside. Among sector peers, Tempus AI fell 3.44%, Danaher fell 2.82%, IQVIA fell 2.27%, Waters fell 2.09%, and Illumina fell 0.6%, reflecting a significant sector-wide linkage effect.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment